Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Scandinibsa is a specialized pharmaceutical company focused on the development and manufacture of local anesthetics, primarily for the dental and surgical markets. As part of the Inibsa Group, the company operates one of the world's largest production plants for dental anesthesia cartridges, supplying products to over 60 countries. Their portfolio includes well-known anesthetic agents such as articaine, lidocaine, and mepivacaine, often formulated with epinephrine. The company maintains high-quality standards with EU-GMP and FDA-compliant manufacturing facilities, positioning itself as a key global player in the dental pain management sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Scandinibsa.